Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Cell Mol Biol (Noisy-le-grand) ; 62(14): 59-63, 2016 Dec 30.
Artigo em Inglês | MEDLINE | ID: mdl-28145858

RESUMO

Due to the approximate clinical and biochemical manifestations of calcium and magnesium disturbances, with regard to the regulatory effects of parathyroid hormone (PTH), this present study is designed to analyze serum calcium (Ca), magnesium (Mg), and (PTH) at the time of birth, 24 hours afterwards in newborns after the mother has been treated with Mg-sulfate. We registered 86 term and preterm neonates (43 in each group) using simple census method delivered through vagina to preeclampsia pregnant women treated with Mg-sulfate immediately before birth in Khoramabad Asali Hospital, Iran. The first specimen was obtained from umbilical cord blood at birth, followed by the second sample of 2cc peripherally obtained from blood 24 hours after birth. The mean serum Mg level was higher than normal for both specimens in both term and preterm groups with no significant difference. The mean serum Ca level was higher in term group at both occasions, which turned out to be statistically significant (P<0.000) and (P=0.001) for the first and second specimens respectively. The mean PTH level was also in normal range for both groups at both times with no statistical significance. On the other hand, magnesium level showed a significant decline at 24 hours (P = 0.005) while PTH increased significantly (p<0.000) and (p=0.005) for term and preterm groups respectively. In contrast, Ca changes were not significantly different between the two specimens. Treatment with Mg-sulfate immediately before vaginal delivery increases Mg in both term and preterm neonates with no effect on Ca and PTH levels.


Assuntos
Cálcio/sangue , Sulfato de Magnésio/uso terapêutico , Magnésio/sangue , Hormônio Paratireóideo/sangue , Pré-Eclâmpsia/sangue , Pré-Eclâmpsia/tratamento farmacológico , Adolescente , Adulto , Distribuição de Qui-Quadrado , Feminino , Humanos , Recém-Nascido , Gravidez , Fatores de Tempo , Resultado do Tratamento , Adulto Jovem
2.
New Microbes New Infect ; 43: 100925, 2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-34336225

RESUMO

The severity of COVID-19 has been to be associated with comorbidities. It is defined as the presentation of severe respiratory dysfunction or failure, leading to the need for ventilation and mortality. The aim of this study is the evaluate the factors predicting the rate of invasive ventilation among these patients. This retrospective study involved 317 COVID-19 patients referred to (XXX) Hospital in Qom, Iran. The following data were obtained for all the patients: demographic parameters, comorbidities, need for mechanical ventilation, signs and symptoms and lab findings. The results from the demographic data of the study indicated that the need for mechanical ventilation is significantly associated with advanced age, p = 0.001. Additionally, hypertension, leukopenia and blood urea nitrogen to creatinine ratio p = 0.008. p = 0.042 and p < 0.001, respectively, are significantly associated with an increased need for mechanical ventilation. Malignancy, diabetes, asthma, chronic obstructive pulmonary disease, headache, fever, platelet count, prothrombin time, c-reactive protein, erythrocyte sedimentation rate and creatinine phosphatase were not significantly different in the two groups, p > 0.05. Prediction of the extent of severity among COVID-19 patients using clinical parameters and comorbidities prepare medical practitioners and health care centres to take immediate measurements and reduce the burden of the scarcity of health supplies and care.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA